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Abstract: Sucrose overfeeding increases intrahepatocellular (IHCL) and intramyocellular (IMCL) lipid
concentrations in healthy subjects. We hypothesized that these effects would be modulated by diet
protein/fat content. Twelve healthy men and women were studied on two occasions in a randomized,
cross-over trial. On each occasion, they received a 3-day 12% protein weight maintenance diet
(WM) followed by a 6-day hypercaloric high sucrose diet (150% energy requirements). On one
occasion the hypercaloric diet contained 5% protein and 25% fat (low protein-high fat, LP-HF), on the
other occasion it contained 20% protein and 10% fat (high protein-low fat, HP-LF). IHCL and IMCL
concentrations (magnetic resonance spectroscopy) and energy expenditure (indirect calorimetry)
were measured after WM, and again after HP-LF/LP-HF. IHCL increased from 25.0 ± 3.6 after WM
to 147.1 ± 26.9 mmol/kg wet weight (ww) after LP-HF and from 30.3 ± 7.7 to 57.8 ± 14.8 after HP-LF
(two-way ANOVA with interaction: p < 0.001 overfeeding x protein/fat content). IMCL increased
from 7.1 ± 0.6 to 8.8 ± 0.7 mmol/kg ww after LP-HF and from 6.2 ± 0.6 to 6.9 ± 0.6 after HP-LF,
(p < 0.002). These results indicate that liver and muscle fat deposition is enhanced when sucrose
overfeeding is associated with a low protein, high fat diet compared to a high protein, low fat diet.
Keywords: sucrose overfeeding; hepatic steatosis; intramyocellular lipids; intrahepatocellular lipids;
dietary protein content; dietary fat content; energy expenditure; plasma triglyceride
1. Introduction
Consumption of hypercaloric high-fructose or high-sucrose diets can lead to the deposition of
fat in ectopic sites such as visceral adipose tissue, the liver (intrahepatocellular lipids, IHCL), skeletal
muscle (intramyocellular lipids, IMCL), the heart, and the pancreas [1]. Such ectopic fat deposition has
been associated with insulin resistance and increased risk of cardiovascular and hepatic disorders [2,3].
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In addition, hypercaloric high-fructose diets have been shown to impair hepatic insulin sensitivity [4,5],
to increase fasting and postprandial blood triglycerides [6,7] and uric acid [8] concentrations, and may
therefore be associated with a particularly ominous constellation of cardiometabolic risk factors.
Most studies that have documented metabolic effects of fructose or sucrose overfeeding have
involved either the addition of fructose or sucrose to a weight maintenance diet, or the substitution of
fructose or sucrose for dietary starch. In real life conditions, however, the addition of sucrose to an
ad libitum diet is expected to impact habitual food consumption and hence to alter both total energy
intake and the dietary macronutrient composition. It has indeed been reported that the addition of
fructose-sweetened beverages to the spontaneous diet of overweight subjects was associated with
a partial suppression of dietary fat and protein intake from solid foods [9]. One may therefore
hypothesize that the metabolic effects of overfeeding depend not only on the amount of excess sucrose,
but also on how it impacts other dietary macronutrient intake. Dietary sucrose and fat content may
have additive effects on IHCL [10]. Interactions between dietary sucrose and protein are also relevant,
since dietary protein intake has been shown to modulate overfeeding-induced ectopic lipid storage:
in rodents fed a high fructose diet, the increase in IHCL was lower when excess dietary fructose
was associated with a high, compared to a low, protein intake [11,12]. Similar observations were
reported for humans overfed with lipids and protein compared to lipids alone [13–15], and with
fructose and essential amino-acids compared with fructose alone [16]. In addition, a high protein
intake is associated with an increase in energy expenditure, and may thus reduce energy storage [17].
We therefore hypothesized that, in normal weight human subjects, a short-term sucrose overfeeding
associated with a high-protein, low-fat intake would blunt intrahepatocellular and intramyocellular
lipid storage compared to the same sucrose overfeeding associated with a low-protein, high-fat diet.
To assess this hypothesis, we carried out a randomized, cross-over controlled trial in 12 healthy male
and female subjects. We monitored IHCL and IMCL, postprandial energy expenditure (EE), and blood
metabolite concentrations at baseline, i.e. after 3 days on a 10% sucrose weight maintenance diet (WM),
and after 6-days overfeeding with 50% extra-energy added as 40% sucrose and 10% lactose with either
a high protein-low fat (HP-LF) or a low protein-high fat (LP-HF) content.
2. Materials and Methods
2.1. Subjects
Twelve healthy and non-obese volunteers (6 males, mean age 21 ± 1 years, weight 71.6 ± 2.3 kg,
BMI 22.5 ± 0.8 kg/m2; 6 females mean age 23 ± 1 years, weight 57.3 ± 0.8 kg, BMI 21.2 ± 0.7 kg/m2)
were included in this study. Volunteers were recruited through advertisements posted at the University
of Lausanne and the Lausanne University Hospital. All volunteers were sedentary (less than 2 h of
strenuous physical activity per week), were nonsmokers, had no lactose intolerance as documented by
a lactose hydrogen breath test [18], and did not take any medication, (except for contraceptive agents
which were used by all female participants). They all provided informed written consent.
2.2. Experimental Protocol
The experimental protocol was approved by the ethical committee (Commission d’éthique
pour la recherche humaine de l’Etat de Vaud, Switzerland), and was registered at clinicaltrials.gov
(NCT02168218). All procedures were performed in accordance with the 1983 revision of the Declaration
of Helsinki. The primary outcome of the study was whole body protein turnover using labelled leucine,
and will be reported separately. IHCL, IMCL and EE, which are the main focus of this paper, were all
secondary outcomes. The experimental protocol is presented in Figure 1.
Nutrients 2019, 11, 209 3 of 12
Nutrients 2019, 11, 209 3 of 12 
 
 
Figure 1. Experimental protocol. Each participant took part in two overfeeding periods according to 
a randomized, cross-over design. WM: weight maintenance diet, LP-HF: hypercaloric (150% energy 
requirement high-sucrose, low protein-high fat); HP-LF: hypercaloric (150% energy requirement 
high-sucrose, high protein-low fat); MRS: magnetic resonance spectroscopy for measurement of IHCL 
and IMCL; M. test: metabolic test, consisting of measurements of energy expenditure, plasma 
hormones, and substrate concentrations after ingestion of WM meal providing 40% of total energy 
requirements (D0), or LP-HF/HP-LF meals providing 60% of total energy requirements. 
2.3. Dietary Interventions 
All participants were studied on two occasions, each one consisting of a 3-day (D-3–D-1) weight-
maintenance (WM), low sucrose diet followed by 6-day of sucrose + lactose overfeeding (D1–D6). On 
one occasion this overfeeding consisted of a 5% dietary protein and 25% fat content; on the other 
occasion, it was comprised of 20% dietary protein and 10% fat content. The dietary conditions were 
applied according to a randomized, cross-over design (Figure 1). Randomization was performed 
according to a pre-defined sequence, which was generated using R, version 3.0.1. (R Foundation for 
Statistical Computing, Vienna, Austria). The intervention was not blinded due to the nature of the 
drinks consumed. The two interventions were separated by a washout period of four to eight weeks.  
WM diets were prepared from market foods and provided 100% of energy requirements 
(estimated from basal energy expenditure, calculated with the Harris-Benedict equation, times a 
physical activity level of 1.5). Food intake was partitioned into 3 meals/day and 2 snacks/day. It 
contained 45% of total energy as starch, 10% as sucrose, 33% as lipid, and 12% as protein and 22.6 ± 
0.9 g dietary fiber/day; beverages were provided ad libitum as water. Overfeeding was attained by 
adding an extra 50% energy to the weight-maintenance energy requirements, in the form of six drinks 
per day. Drinks were prepared with skimmed milk and sucrose for the HP-LF condition or with 
water, lactose, and sucrose for the LP-HF condition, and had a volume of 218 ± 52 ml each. Solid diets 
were adjusted to obtain the same total energy (150% energy requirement): starch (29%), sucrose (34%) 
and lactose (7%) in both diets, with 20% protein (2.7 g/kg/day) and 10% fat in HP-LF or 5% protein 
(0.8 g/kg/day) and 25% fat in LP-HF. The addition of fat in LP-HF was mainly achieved by the 
addition of olive oil, butter, sauces, and cereals bars. Water consumption was left ad libitum. The 
detailed compositions of all three diets are shown in Table 1. 
During each intervention, participants came to the metabolic unit of the Physiology Department 
of the University of Lausanne to consume their breakfasts, lunches, dinners, and three supplemental 
drinks under supervision. Every day, they also received two packages of snacks, together with three 
supplemental drinks during the overfeeding periods to consume between main meals, and were 
instructed not to consume any other food or drinks except plain water.  
  
WM
MRS M. test
LP-HF
D-3 D-2 D-1 D-0 D1 D2 D3 D4 D5 D6 D7
Wash-out: 4-8 weeks
HP-LF
MRS M. test
MRS M. test M. testMRS
WM
Figure 1. Experimental protocol. Each participant took part in two overfeeding periods according to
a randomized, cross-over design. WM: weight maintenance diet, LP-HF: hypercaloric (150% energy
requirement high-sucrose, low protein-high fat); HP-LF: hypercaloric (150% energy requirement
high-sucrose, high protein-low fat); MRS: magnetic resonance spectroscopy for measurement of IHCL
and IMCL; M. test: metabolic test, consisting of measurements of energy expenditure, plasma hormones,
and substrate concentrations after ingestion of WM meal providing 40% of total energy requirements
(D0), or LP-HF/HP-LF meals providing 60% of total energy requirements.
2.3. Dietary Interventions
All participants were studied on two occasions, each one consisting of a 3-day (D-3–D-1)
weight-maintenance (WM), low sucrose diet followed by 6-day of sucrose + lactose overfeeding
(D1–D6). On one occasion this overfeeding consisted of a 5% dietary protein and 25% fat content; on
the other occasion, it was comprised of 20% dietary protein and 10% fat content. The dietary conditions
were applied according to a randomized, cross-over design (Figure 1). Randomization was performed
according to a pre-defined sequence, which was generated using R, version 3.0.1. (R Foundation for
Statistical Computing, Vienna, Austria). The intervention was not blinded due to the nature of the
drinks consumed. The two interventions were separated by a washout period of four to eight weeks.
WM diets were prepared from market foods and provided 100% of energy requirements (estimated
from basal energy expenditure, calculated with the Harris-Benedict equation, times a physical activity
level of 1.5). Food intake was partitioned into 3 meals/day and 2 snacks/day. It contained 45% of
total energy as starch, 10% as sucrose, 33% as lipid, and 12% as protein and 22.6 ± 0.9 g dietary
fiber/day; beverages were provided ad libitum as water. Overfeeding was attained by adding an extra
50% energy to the weight-maintenance energy requirements, in the form of six drinks per day. Drinks
were prepared with skimmed milk and sucrose for the HP-LF condition or with water, lactose, and
sucrose for the LP-HF condition, and had a volume of 218 ± 52 ml each. Solid diets were adjusted to
obtain the same total energy (150% energy requirement): starch (29%), sucrose (34%) and lactose (7%)
in both diets, with 20% protein (2.7 g/kg/day) and 10% fat in HP-LF or 5% protein (0.8 g/kg/day)
and 25% fat in LP-HF. The addition of fat in LP-HF was mainly achieved by the addition of olive oil,
butter, sauces, and cereals bars. Water consumption was left ad libitum. The detailed compositions of
all three diets are shown in Table 1.
During each intervention, participants came to the metabolic unit of the Physiology Department
of the University of Lausanne to consume their breakfasts, lunches, dinners, and three supplemental
drinks under supervision. Every day, they also received two packages of snacks, together with three
supplemental drinks during the overfeeding periods to consume between main meals, and were
instructed not to consume any other food or drinks except plain water.
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Table 1. Energy content and macronutrient composition of WM, LP-HF and HP-LF.
Diet
Composition
WM LP-HF HP-LF
Solid Diet
kcal/day (%)
Beverages
kcal/day (%)
Solid Diet
kcal/day (%)
Beverages
kcal/day (%)
Total LP-HF
kcal/day (%)
Solid Diet
kcal/day (%)
Beverages
kcal/day (%)
Total HP-LF
kcal/day (%)
Starch 1061 (45) - 1054 - 1054 (29) 1043 - 1043 (29)
Sucrose 249 (10) - 241 965 1206 (34) 246 964 1210 (34)
Lactose - - - 245 245 (7) - 246 246 (7)
Protein 274 (12) - 194 - 194 (5) 514 178 692 (20)
Fat 781 (33) - 886 - 886 (25) 357 12 369 (10)
SFA 263 (34) - 313 - 313 (35) 184 - 184 (52)
MUFA 280 (36) - 389 - 389 (44) 102 - 102 (29)
PUFA 202 (26) - 168 - 168 (19) 55 - 55 (15)
Total kcal 2365 - 2375 1210 3585 2160 1400 3560
WM: weight maintenance diet; LP-HF: high-sucrose, low-protein; HP-LF: high-sucrose, high-protein. Data are
expressed as kcal/day; values into bracket represent % of total energy intake. For SFA, MUFA and PUFA, values
in () are given as % total fat intake.
2.4. Measurements of IHCL and IMCL
For each intervention, IHCL and IMCL were measured at 4:00 pm on the 3rd day (D-1) on the
WM diet (WMLP-HF and WMHP-LF) and on the 6th day (D6) on the hypercaloric diets (HP-LF and
LP-HF). IHCL and IMCL content were determined by 1H-MRS using a clinical 3T MR system (Verio,
Siemens Medical, Germany) using methods similar to those described previously for IMCL [19,20]
and for IHCL [21]. For the latter, quantification was based on the unsuppressed water signal corrected
for transverse relaxation (characterized by the T2 value) as determined in each subject individually.
Since T2 values were found to be significantly different before (WMLP-HF, WMHP-LF) versus after the
diets (LP-HF, HP-LF), but did not differ between diets (LP-HF vs. HP-LF), individually averaged T2
values for pre- and post-diet sessions were used for IHCL quantification. Results were expressed as
mmol/kg ww.
2.5. Metabolic Tests
On days following IHCL and IMCL measurements (D0 and D7), participants were asked to
arrive in the fasting state at the Metabolism, Nutrition and Physical Activity Research Center of the
Department of Physiology of the University of Lausanne at 7:00 am for a metabolic test (schema shown
in Figure 2). They had performed a 24-h urine collection the day before.Nutrients 2019, 11, 209 5 of 12 
 
 
Figure 2. Schema of metabolic tests at D0 and D7. 
2.6. Analytical Procedures 
Plasma glucose, triglycerides (TG), lactate, and urine urea were measured by enzymatic methods 
(Randox Laboratories, Crumlin, County Antrim, UK). Plasma fructose concentrations were measured 
by GC–MS apparatus (Agilent Technologies, Santa Clara, CA, USA) [23]. Insulin and glucagon were 
assessed by radioimmunoassays (Millipore, Billerica, MA, USA). Plasma lipoprotein subfractions 
were separated by ultracentrifugation [24].  
2.7. Statistical Analysis 
All results are expressed as means ± SEMs. Postprandial results for all parameters (except for 
IGF1 and glucagon, which were determined in fasting conditions at only 2-time points postprandial) 
were expressed as the incremental area under the curve (iAUC (0-300 min)), which was obtained using 
the trapezoidal method by subtracting the fasting value. As a preliminary analysis, the normality of 
data was checked with Shapiro-Wilk tests for all parameters analyzed. Non-normally distributed 
data were log-transformed (IHCL, fasting insulin, glucagon, TG, and postprandial glucagon). Two-
way ANOVA assessed the effects of overfeeding, protein/fat content (HP-LF vs. LP-HF), and 
interaction between overfeeding x protein/fat content with repeated measures. Tukey post hoc tests 
were performed to compare individuals when needed. All statistical analyses were performed using 
Prism 7 (GraphPad Software, Inc., La Jolla, USA). The number of subjects included in the study was 
based on a power analysis related to whole body protein turnover (not reported here). 
3. Results 
The recruitment and follow up of subjects took place between June 2013 and April 2016. All 
volunteers completed the investigation and reported that they did not take any additional caloric 
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concentration, excretion, and clearance calculation due to missing urine collections. All other 
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Fasting parameters are shown in Table 2. All fasting parameters were not significantly different 
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Figure 2. Schema of metabolic tests at D0 and D7.
This metabolic test aimed at comparing their fasting and postprandial energy expenditure,
plasma hormones, and substrate profiles during periods of weight maintenance and overfeeding. At
their arrival, participants were asked to void and discard their urine. They were then weighed and
transferred to a bed where they remained in a semi-recumbent position for the next 7.5 h. A catheter
was inserted into an antecubital vein for blood collection. Subjects remained fasted for the initial 2.5 h.
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Four fasting blood samples and a urine collection were obtained during this period. Thereafter, they
received two meals, one at 150 min and the second one at 330 min. Meal composition corresponded to
the current intervention (i.e., WM on D0 and either HP-LF or LP-HF on D7). The sum of these two
meals contained 40% (30% in first and 10% in the second meal) of total daily energy intake, which
corresponded to 40% of energy requirements with WM, and to 60% of daily energy requirements
during overfeeding periods (HP-LF and LP-HF). Postprandial blood samples were collected at the
times 210 min, 270 min, 330 min, 390 min, and 450 min. Respiratory gas exchanges were monitored
throughout the experiment by open-circuit indirect calorimetry (Quark RMR, version 9.1b, Cosmed,
Rome, Italy), except for brief interruptions during meals. A second urine collection was obtained at the
end of the test (time 450 min). Energy expenditure (EE) was calculated using the equations of Livesey
and Elia [22].
2.6. Analytical Procedures
Plasma glucose, triglycerides (TG), lactate, and urine urea were measured by enzymatic methods
(Randox Laboratories, Crumlin, County Antrim, UK). Plasma fructose concentrations were measured
by GC–MS apparatus (Agilent Technologies, Santa Clara, CA, USA) [23]. Insulin and glucagon were
assessed by radioimmunoassays (Millipore, Billerica, MA, USA). Plasma lipoprotein subfractions were
separated by ultracentrifugation [24].
2.7. Statistical Analysis
All results are expressed as means ± SEMs. Postprandial results for all parameters (except for
IGF1 and glucagon, which were determined in fasting conditions at only 2-time points postprandial)
were expressed as the incremental area under the curve (iAUC (0-300 min)), which was obtained using the
trapezoidal method by subtracting the fasting value. As a preliminary analysis, the normality of data
was checked with Shapiro-Wilk tests for all parameters analyzed. Non-normally distributed data were
log-transformed (IHCL, fasting insulin, glucagon, TG, and postprandial glucagon). Two-way ANOVA
assessed the effects of overfeeding, protein/fat content (HP-LF vs. LP-HF), and interaction between
overfeeding x protein/fat content with repeated measures. Tukey post hoc tests were performed to
compare individuals when needed. All statistical analyses were performed using Prism 7 (GraphPad
Software, Inc., La Jolla, USA). The number of subjects included in the study was based on a power
analysis related to whole body protein turnover (not reported here).
3. Results
The recruitment and follow up of subjects took place between June 2013 and April 2016. All
volunteers completed the investigation and reported that they did not take any additional caloric drinks
and food during the study. One volunteer was not included in the calculation of postprandial fructose
due to missing plasma samples. Two volunteers were excluded from 24 h urinary concentration,
excretion, and clearance calculation due to missing urine collections. All other calculations were
performed with all 12 volunteers.
3.1. Fasting Condition
Fasting parameters are shown in Table 2. All fasting parameters were not significantly different
after WMLP-HF and WMHP-LF. Body weight increased by 0.7 ± 0.1 kg (males 0.9 ± 0.2 kg, females
0.6 ± 0.1 kg) between D0 and D7 after LP-HF and by 1.4 ± 0.2 kg after HP-LF (males 1.8 ± 0.2 kg,
females 0.9 ± 0.1 kg) (for the whole group: p < 0.001 for overfeeding, p > 0.999 for protein/fat content,
p = 0.009 for overfeeding × protein/fat content). Fasting EE increased from 1.11 ± 0.06 kcal/min
(WMLP-HF) to 1.12 ± 0.05 kcal/min (LP-HF), and from 1.10 ± 0.05 kcal/min (WMHP-LF) to 1.18 ± 0.05
kcal/min (HP-LF), (p = 0.018 for overfeeding, p = 0.126 for protein/fat content, p = 0.024 overfeeding
x protein/fat content). Fasting plasma glucose, fructose, lactate, TG, and insulin all increased to the
same extent with HP-LF and LP-HF (Table 2). Fasting plasma NEFA decreased to the same extent with
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HP-LF and LP-HF. In contrast, fasting glucagon concentration and IGF-1 concentrations increased with
HP-LF, but remained stable (glucagon) or slightly decreased (IGF-1) with LP-HF.
Table 2. Fasting plasma metabolites and hormones concentrations.
Fasting WM
(LP-HF) LP-HF
WM
(HP-LF) HP-LF
p Value
Overfeeding Protein/Fat Content OxP
Glucose (mmol/L) 4.56 ± 0.07 4.78 ± 0.07 4.46 ± 0.11 4.76 ± 0.09 <0.001 0.444 0.383
Fructose (µmol/L) 25.95 ± 1.41 27.15 ± 1.49 26.35 ± 1.37 28.0 ± 1.32 0.022 0.611 0.750
Lactate (mmol/L) 0.70 ± 0.06 1.22 ± 0.07 0.64 ± 0.04 1.16 ± 0.09 <0.001 0.107 0.935
Uric acid (mmol/L) 0.38 ± 0.02 0.38 ± 0.03 0.39 ± 0.02 0.30 ± 0.02 <0.001 <0.001 <0.001
TG (mmol/L) 0.68 ± 0.07 1.54 ± 0.22 0.66 ± 0.08 1.68 ± 0.19 <0.001 0.429 0.119
NEFA (mmol/L) 0.72 ± 0.05 0.44 ± 0.09 0.77 ± 0.04 0.37 ± 0.07 <0.001 0.779 0.097
Insulin (µU/mL) 8.42 ± 0.83 10.95 ± 1.02 7.82 ± 0.79 11.73 ± 1.54 <0.001 0.744 0.295
Glucagon (pg/mL) 72.42 ± 4.83 72.49 ± 4.94 68.67 ± 4.03 79.27 ± 5.35 0.059 0.276 0.036
IGF-1 (ng/mL) 212 ± 13 176 ± 12 174 ± 18 208 ± 13 0.901 0.712 <0.001
WM: weight maintenance diet; LP-HF: high-sucrose, low-protein; HP-LF: high-sucrose, high-protein. All values are
mean ± SEM, n = 12. A significant difference in each condition, p < 0.05 (2-way ANOVA with repeated measures).
OxP: Overfeeding x protein/fat content.
3.2. IHCL and IMCL Concentrations
IHCL and IMCL concentrations after WM and after LP-HF and HP-LF are shown in Figure 3.
No statistically significant difference was observed between WMLP-HF and WMHP-LF. Compared to
WM conditions, IHCL and IMCL concentrations increased significantly with both LP-HF and HP-LF
overfeeding. However, IHCL increased more importantly with LP-HF than with HP-LF (p < 0.001 for
effect of overfeeding, p < 0.001 for effect of dietary protein/fat content, and p < 0.001 for interaction
overfeeding x protein/fat content). IMCL also increased more with LP-HF than with HP-LF (p < 0.001
for overfeeding, p = 0.025 for protein/fat content, and p = 0.002 for overfeeding x protein/fat content).
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3.3. Postprandial Parameters
Postprandial metabolic parameters were not significantly different after WM diets. Postprandial
EE and diet-induced thermogenesis were both significantly higher with LP-HF and HP-LF than under
their respective WM conditions. Furthermore, EE increased more after HP-LF (from 1.23 ± 0.05
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to 1.55 ± 0.06 kcal/min) than after LP-HF (from 1.24 ± 0.05 to 1.41 ± 0.06 kcal/min) (p < 0.001 for
overfeeding, p = 0.013 for protein/fat content, and p < 0.001 for overfeeding x protein/fat content).
The postprandial iAUCs for blood metabolites and hormones are shown in Table 3. Postprandial
blood glucose did not significantly change with HP-LF and LP-HF compared to their respectively WM
conditions. Postprandial fructose, lactate, TG, and insulin iAUC were significantly higher in HP-LF
and LP-HF than in the respective WM conditions.
Table 3. Metabolites and hormones at postprandial states.
Postprandial WM (LP-HF) LP-HF WM (HP-LF) HP-LF
p Value
Overfeeding Protein/Fat Content OxP
iAUC Glucose (mmol/L*300min) 504.0 ± 40.5 495.3 ± 69.2 560.3 ± 43.7 471.4 ± 57.2 0.242 0.616 0.189
iAUC Fructose (mmol/L*300min) 4.2 ± 0.3 30.3 ± 2.9 4.8 ± 0.5 23.4 ± 2.2 <0.001 0.005 0.003
iAUC Lactate (mmol/L*300min) 78.8 ± 12.8 239.8 ± 24.5 92.2 ± 15.1 139.3 ± 15.7 <0.001 0.001 0.001
iAUC TG (mmol/L*300min) 29.3 ± 6.8 121.3 ± 15.3 24.2 ± 8.0 126.7 ± 16.9 <0.001 0.986 0.471
iAUC NEFA (mmol/L*300min) −162.6 ± 12.5 −86.7 ± 23.2 −173.1 ± 11.0 −76.6 ± 17.2 <0.001 0.984 0.051
iAUC Insulin (µU/ml*300min) 11378 ± 1232 19228 ± 1708 11138 ± 1488 24123 ± 2790 <0.001 0.061 0.028
WM: weight maintenance diet; LP-HF: high-sucrose, low-protein; HP-LF: high-sucrose, high-protein. All values are
mean ± SEM, n = 12. A significant difference in each condition, p < 0.05 (2-way ANOVA, with repeated measures).
OxP: Overfeeding x protein/fat content. In the calculation of iAUC fructose (n = 11) one volunteer was excluded for
reason of missing plasma data.
HP-LF and LP-HF nonetheless differentially altered postprandial insulin, fructose, and lactate
concentrations: HP-LF increased postprandial insulin concentrations more than LP-HF, but decreased
postprandial fructose and lactate (see Table 3 for detailed statistics). Postprandial plasma uric acid
concentration, measured at time 450 min, decreased from 0.38 ± 0.02 (WM) to 0.30 ± 0.02 mmol/L
with HP-LF, but increased from 0.38 ± 0.03 (WM) to 0.42 ± 0.04 mmol/L with LP-HF (p = 0.283 for
overfeeding, p = 0.001 for diet, p < 0.001 for overfeeding × protein/fat content). Plasma glucagon,
measured at time 450 min, increased from 62.6 ± 3.3 to 87.9 ± 8.4 pg/mLwith HP-LF, but did not
change with LP-HF: 65.1 ± 4.4 vs. LP-HF: 70.6 ± 4.8 pg/mL, (p < 0.001 for overfeeding, p = 0.026 for
protein/fat content, and p = 0.001 for overfeeding x protein/fat content).
24-h urinary excretion and clearance of creatinine and uric acid are shown in Table 4. LP-HF and
HP-LF did not significantly change 24-h urinary excretion and clearance of creatinine. HP-LF increased
urinary excretion of uric acid and uric acid clearance while LP-HF decreased it. Compared to LP-HF,
HP-LF significantly increased urinary creatinine and uric acid clearance; it also increased total 24-h
uric acid excretion.
Table 4. 24-h urinary creatinine and uric acid excretion and clearance.
WM
(LP-HF) LP-HF
WM
(HP-LF) HP-LF
p Value
Overfeeding Protein/Fat Content OxP
24-h urinary excretion
Creatinine (mmol/24h) 13.6 ± 1.8 12.6 ± 1.2 13.0 ± 0.8 12.7 ± 1.1 0.264 0.450 0.638
Uric acid (mmol/24h) 3.5 ± 0.2 3.3 ± 0.2 3.3 ± 0.2 4.1 ± 0.4 0.049 0.238 0.022
Urinary clearance rate
Creatinine (ml/min) 129.8 ± 9.4 133.7 ± 9.7 135.1 ±10.8
153.0 ±
13.0 0.279 0.309 0.282
Uric acid (ml/min) 6.9 ± 0.6 6.5 ± 0.6 6.1 ± 0.4 10.0 ± 1.4 0.005 0.015 0.004
WM: weight maintenance diet; LP-HF: high-sucrose, low-protein; HP-LF: high-sucrose, high-protein. All values are
mean ± SEM, n = 10 as two volunteers were excluded because of missing samples. A significant difference in each
condition, p < 0.05 (2-way ANOVA, with repeated measures). OxP: Overfeeding x protein/fat content.
4. Discussion
This study was designed to assess whether the consequences of sucrose overfeeding differ
according to concomitant changes in daily protein and fat intake. Our main findings were that both
HP-LF and LP-HF increased IHCL, IMCL, and blood triglycerides concentrations, but increments
were reduced on average by 78% for IHCL and by 59% for IMCL with HP-LF compared to LP-HF.
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In addition, fasting and postprandial EE were significantly higher with HP-LF than LP-HF. However,
blood triglyceride concentrations were not significantly different with HP-LF and LP-HF. Finally, blood
uric acid concentrations were increased with LP-HF, but decreased with HP-LF.
Our experimental design compared the effects of two hypercaloric high sucrose diets, one
with a high protein-low fat content and the other with a low protein-high fat content, to that of
a weight maintenance control diet. All three diets contained an amount of starch equivalent to
approximately 45% total energy requirements, and the two hypercaloric diets contained 150% of
daily energy requirements, with about 50% of energy requirements as sucrose, and 7% of energy
requirements as lactose. Lactose intake was higher in HP-LF than in WM because of a high milk
protein intake and was balanced by lactose addition in LP-HF in order to have equal carbohydrate
amounts and composition in both diets. Dietary saturated-monounsaturated and polyunsaturated
fatty acid proportions were also different in each diet.
The dietary composition had a profound effect on the amount of ectopic lipids being deposited
during overfeeding. HP-LF and LP-HF both increased lipid storage in the liver and muscle, two
sites in which ectopic lipid deposition is known to be associated with adverse long-term effects [1].
Several short-term studies had previously documented that excess energy intake from fructose or
glucose increased IHCL [10,25,26] and IMCL [26–28]. In our study, this effect was most notable in
the liver, where IHCL increased by 542 ± 105% after LP-HF. It was milder in skeletal muscle, where
we nonetheless observed a significant increase of +24 ± 3% after LP-HF. In both sites, the increases
induced by HP-LF were significantly lower than those induced by LP-HF. Excess energy intake from
sugars is thought to increase IHCL by enhancing hepatic de novo lipogenesis and inhibiting intrahepatic
lipid oxidation [29]. Several hypotheses can be proposed to account for the differential effects of HP-LF
and LP-HF. First, LP-HF contained more lipids than HP-LF. Previous experiments have shown that fat
overfeeding increases IHCL synthesis from intestinally derived TG-rich lipoprotein particles and/or
circulating NEFA [13,30,31]. It has also been shown that fructose and fat have additive effects on
IHCL during combined fructose-fat overfeeding [10]. It is therefore likely that, with LP-HF, the high
dietary sugar and fat intake had additive effects on IHCL. Second, dietary protein may decrease IHCL
independently of dietary fat or energy intake. In support of this hypothesis, a former study reported
that IHCL were increased in healthy subjects fed a hypercaloric, high fat diet containing 130% energy
requirements. However, the addition of protein to this high fat diet resulted in a similar daily fat and
carbohydrate intake, but also in a higher total energy and protein intake with significantly reduced
IHCL [13]. The mechanisms by which an increased protein intake may reduce IHCL remain unknown.
Inhibition of de novo lipogenesis has been postulated [13], but fractional hepatic de novo lipogenesis
was stimulated to the same extent in healthy subjects overfed with fructose alone or with fructose and
proteins [16]. A stimulation of hepatic VLDL-TG secretion and extrahepatic VLDL-TG clearance [16],
or a protein-induced increase in plasma bile acid concentrations [13] have also been proposed to play
a role. In contrast, no effect of dietary protein intake on IMCL has been reported to our knowledge.
Finally, changes in dietary fatty acids composition may modulate diet-induced hepatic fat deposition
(reviewed in reference [32]). Hepatic steatosis in animal models is readily produced by consumption of
a high saturated fat diet with low PUFA content. In contrast, there is evidence that PUFA or oleic acid
supplementation may actually blunt diet-induced hepatic steatosis [32]. In the present study, dietary
protein intake in HP-LF was increased through the consumption of skimmed dairy products to avoid
an increase in SFA, and dietary fat intake in LP-HF was increased by consumption of vegetable oils
(mainly olive oil). As a result, total daily SFA intake was only slightly higher in LP-HF than in HP-LF
(34.7 ± 1.5 vs. 20.4 ± 0.9 g/day) while MUFA+PUFA intake was markedly increased. It is therefore
unlikely that the higher IHCL observed with LP-HF can be explained by the differences in dietary
fat composition.
The postprandial increases in plasma TG concentrations were 5-fold higher with HP-LF and 4-fold
higher with LP-HF than with WM. Several studies have reported that fructose and sucrose overfeeding
increases fasting and postprandial blood triglyceride by increasing hepatic de novo lipogenesis and
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VLDL-TG secretion and by decreasing the postprandial clearance of triglyceride-rich lipoprotein
particles [27,33,34]. It is therefore likely that an upregulation of lipogenic enzymes with sucrose
overfeeding contributed to this hypertriglyceridemia. However, the meals administered during the
metabolic tests contained 50% more total energy in overfeeding than in weight-maintenance control
conditions, and, therefore, contained also more sucrose and fat, which makes it difficult to sort out
the relative role of sucrose and other macronutrients. Globally, the increase in postprandial TG
concentrations was not significantly different in HP-LF and LP-HF.
The effect of overfeeding on energy expenditure was also markedly dependent on dietary
composition. Postprandial EE increased significantly with both HP-LF and LP-HF, mainly due to the
fact that the test meals ingested in both conditions had a caloric content 50% higher than in the control
weight-maintenance condition. Postprandial EE increased more with HP-LF than LP-HF. This is most
likely explained by the high energy cost of amino-acid metabolism [35].
We also assessed whether dietary composition had significant effects on postprandial blood
metabolic markers during overfeeding. The total carbohydrate and sucrose content of meals ingested
during the metabolic tests were higher in overfeeding than in the WM control condition, and
postprandial increments in blood fructose, lactate, and insulin were accordingly enhanced. Similarly,
postprandial NEFA was decreased to lower levels in overfeeding than in WM conditions. However,
postprandial blood glucose responses were not significantly altered. Most postprandial parameters
were not significantly different in HP-LF and LP-HF overfeeding. However, postprandial glucagon
increased more with HP-LF than with LP-HF, as expected due to the well-known stimulation of
glucagon secretion by circulating amino-acids after protein ingestion [36]. Surprisingly, blood fructose
and lactate concentration increased less with HP-LF than LP-HF. It is possible that the lower lactate
concentration was secondary to glucagon stimulating hepatic lactate uptake [37]. The lower fructose
response was unexpected, however, and may suggest that hepatic fructose extraction was enhanced
when consumed with proteins. Nutrient- or glucagon-mediated changes in portal blood flow may also
be implicated [38]. Alternatively, it is possible that gastric emptying was delayed with HP-LF meals,
thus accounting for a slower fructose absorption [39]. Finally, compared to WM, postprandial increases
in uric acid were higher with LP-HF, but lower with HP-LF, while urinary uric acid excretion and uric
acid clearance were significantly increased with HP-LF. This suggests that both HP-LF and LP-HF
increased uric acid production, possibly due to the fructose component of sucrose [40], and that an
increase in glomerular filtration rate, possibly mediated by glucagon [41], increased uric acid excretion,
thus preventing an increase in blood uric acid. Elevated lactate concentrations are also known to
impair renal uric acid clearance [42], and it is, therefore, possible that lower lactate concentrations
during HP-LF than LP-HF overfeeding also played a role. Our data, however, do not allow accurate
comparisons of uric acid production and excretion between HP-LF and LP-HF.
The present study limitations need to be acknowledged. First, we did not include isotopic
measurements of de novo lipogenesis and VLDL-TG kinetics, and therefore cannot identify the
mechanisms by which HP-LF decreased IHCL and IMCL compared to LP-HF. Second, not only
total dietary fat intake, but also the proportions of SFA-MUFA-PUFA were different between diets,
and we cannot exclude the possibility that this may have impacted IHCL or IMCL storage. Third, in
HP-LF condition, dietary protein content was increased by addition of dairy products; whether the
observed effects are generic to dietary proteins or specific to dairy products remains to be evaluated.
Finally, our study was of short duration and was limited to a small group of healthy male and female
subjects, and results may not apply to other subgroups of the population (e.g., overweight subjects or
subjects with the metabolic syndrome).
5. Conclusions
In summary, our data indicate that overfeeding with a high sucrose, high protein/low-fat diet
markedly reduces ectopic fat accumulation in the liver and muscle, and increases energy expenditure,
compared to an isocaloric overfeeding with high sucrose, low protein/high-fat diet. This may be due
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to an additive effect of sucrose and dietary fat and/or a protective effect of dietary protein on ectopic
fat accumulation.
Author Contributions: Conceptualization, L.E., C.B., R.K., and L.T.; methodology, P.S., C.B., R.K, V.C.; validation,
V.C., A.S., P.J.; formal analysis, A.S.; investigation, A.S., P.J., V.C., L.E., A.-S.M., R.K., V.L., R.R., B.P, J.C.;
writing—original draft preparation, A.S.; writing—review and editing, all.; visualization, A.S., P.J.; project
administration, A.S.; funding acquisition, L.T., C.B., R.K.
Funding: This research was funded by grant from the Swiss National Foundation for science 32003B_156167, and
by a grant from the Institute Benjamin Delessert Foundation to P.J.
Acknowledgments: We thank the staff of the Department of Physiology of Lausanne for their great assistance,
Shawna McCallin for language editing, and all the volunteers for their participation and commitment.
Conflicts of Interest: L.T. has received research support from Soremartec Italia srl for projects unrelated to this
report, and speakers’ fees from Soremartec Italia srl, Nestlé AG, Switzerland, and the Gatorade Sport Science
Institute, USA. L.E. and V.C. are presently employed by Nestec SA, Switzerland. Other authors declare no conflict
of interest.
References
1. Szendroedi, J.; Roden, M. Ectopic lipids and organ function. Curr. Opin. Lipidol. 2009, 20, 50–56. [CrossRef]
2. Morelli, M.; Gaggini, M.; Daniele, G.; Marraccini, P.; Sicari, R.; Gastaldelli, A. Ectopic fat: The true culprit
linking obesity and cardiovascular disease? Thromb. Haemost. 2013, 110, 651–660. [CrossRef] [PubMed]
3. Britton, K.A.; Fox, C.S. Ectopic fat depots and cardiovascular disease. Circulation 2011, 124, e837–e841.
[CrossRef] [PubMed]
4. Stanhope, K.L.; Havel, P.J. Fructose consumption: Considerations for future research on its effects on adipose
distribution, lipid metabolism, and insulin sensitivity in humans. J. Nutr. 2009, 139, 1236S–1241S. [CrossRef]
[PubMed]
5. Aeberli, I.; Hochuli, M.; Gerber, P.A.; Sze, L.; Murer, S.B.; Tappy, L.; Spinas, G.A.; Berneis, K. Moderate
amounts of fructose consumption impair insulin sensitivity in healthy young men: A randomized controlled
trial. Diabetes Care 2013, 36, 150–156. [CrossRef] [PubMed]
6. Stanhope, K.L.; Havel, P.J. Fructose consumption: Potential mechanisms for its effects to increase visceral
adiposity and induce dyslipidemia and insulin resistance. Curr. Opin. Lipidol. 2008, 19, 16–24. [CrossRef]
7. Stanhope, K.L.; Schwarz, J.M.; Keim, N.L.; Griffen, S.C.; Bremer, A.A.; Graham, J.L.; Hatcher, B.; Cox, C.L.;
Dyachenko, A.; Zhang, W.; et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases
visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig.
2009, 119, 1322–1334. [CrossRef]
8. Wang, D.D.; Sievenpiper, J.L.; de Souza, R.J.; Chiavaroli, L.; Ha, V.; Cozma, A.I.; Mirrahimi, A.; Yu, M.E.;
Carleton, A.J.; Di Buono, M.; et al. The effects of fructose intake on serum uric acid vary among controlled
dietary trials. J. Nutr. 2012, 142, 916–923. [CrossRef]
9. Taskinen, M.R.; Soderlund, S.; Bogl, L.H.; Hakkarainen, A.; Matikainen, N.; Pietilainen, K.H.; Rasanen, S.;
Lundbom, N.; Bjornson, E.; Eliasson, B.; et al. Adverse effects of fructose on cardiometabolic risk factors and
hepatic lipid metabolism in subjects with abdominal obesity. J. Intern. Med. 2017, 282, 187–201. [CrossRef]
10. Sobrecases, H.; Le, K.A.; Bortolotti, M.; Schneiter, P.; Ith, M.; Kreis, R.; Boesch, C.; Tappy, L. Effects of
short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men.
Diabetes Metab. 2010, 36, 244–246. [CrossRef]
11. Hamad, E.M.; Taha, S.H.; Abou Dawood, A.G.; Sitohy, M.Z.; Abdel-Hamid, M. Protective effect of whey
proteins against nonalcoholic fatty liver in rats. Lipids Health Dis. 2011, 10, 57. [CrossRef] [PubMed]
12. Chaumontet, C.; Even, P.C.; Schwarz, J.; Simonin-Foucault, A.; Piedcoq, J.; Fromentin, G.;
Azzout-Marniche, D.; Tome, D. High dietary protein decreases fat deposition induced by high-fat and
high-sucrose diet in rats. Br. J. Nutr. 2015, 114, 1132–1142. [CrossRef] [PubMed]
13. Bortolotti, M.; Kreis, R.; Debard, C.; Cariou, B.; Faeh, D.; Chetiveaux, M.; Ith, M.; Vermathen, P.; Stefanoni, N.;
Le, K.A.; et al. High protein intake reduces intrahepatocellular lipid deposition in humans. Am. J. Clin. Nutr.
2009, 90, 1002–1010. [CrossRef] [PubMed]
Nutrients 2019, 11, 209 11 of 12
14. Martens, E.A.; Gatta-Cherifi, B.; Gonnissen, H.K.; Westerterp-Plantenga, M.S. The potential of a high
protein-low carbohydrate diet to preserve intrahepatic triglyceride content in healthy humans. PLoS ONE
2014, 9, e109617. [CrossRef] [PubMed]
15. Rietman, A.; Schwarz, J.; Blokker, B.A.; Siebelink, E.; Kok, F.J.; Afman, L.A.; Tome, D.; Mensink, M.
Increasing protein intake modulates lipid metabolism in healthy young men and women consuming a
high-fat hypercaloric diet. J. Nutr. 2014, 144, 1174–1180. [CrossRef] [PubMed]
16. Theytaz, F.; Noguchi, Y.; Egli, L.; Campos, V.; Buehler, T.; Hodson, L.; Patterson, B.W.; Nishikata, N.;
Kreis, R.; Mittendorfer, B.; et al. Effects of supplementation with essential amino acids on intrahepatic lipid
concentrations during fructose overfeeding in humans. Am. J. Clin. Nutr. 2012, 96, 1008–1016. [CrossRef]
[PubMed]
17. Bray, G.A.; Smith, S.R.; de Jonge, L.; Xie, H.; Rood, J.; Martin, C.K.; Most, M.; Brock, C.; Mancuso, S.;
Redman, L.M. Effect of dietary protein content on weight gain, energy expenditure, and body composition
during overeating: A randomized controlled trial. JAMA 2012, 307, 47–55. [CrossRef] [PubMed]
18. Eisenmann, A.; Amann, A.; Said, M.; Datta, B.; Ledochowski, M. Implementation and interpretation of
hydrogen breath tests. J. Breath Res. 2008, 2, 046002. [CrossRef]
19. Le, K.A.; Faeh, D.; Stettler, R.; Ith, M.; Kreis, R.; Vermathen, P.; Boesch, C.; Ravussin, E.; Tappy, L. A 4-wk
high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy
humans. Am. J. Clin. Nutr. 2006, 84, 1374–1379. [CrossRef]
20. Boesch, C.; Kreis, R. Observation of intramyocellular lipids by 1h-magnetic resonance spectroscopy. Ann. N.
Y. Acad. Sci. 2000, 904, 25–31. [CrossRef]
21. Cros, J.; Pianezzi, E.; Rosset, R.; Egli, L.; Schneiter, P.; Cornette, F.; Pouymayou, B.; Heinzer, R.; Tappy, L.;
Kreis, R.; et al. Impact of sleep restriction on metabolic outcomes induced by overfeeding: A randomized
controlled trial in healthy individuals. Am. J. Clin. Nutr. 2019. [CrossRef] [PubMed]
22. Elia, M.; Livesey, G. Energy expenditure and fuel selection in biological systems: The theory and practice
of calculations based on indirect calorimetry and tracer methods. World Rev. Nutr. Diet. 1992, 70, 68–131.
[PubMed]
23. Tran, C.; Jacot-Descombes, D.; Lecoultre, V.; Fielding, B.A.; Carrel, G.; Le, K.A.; Schneiter, P.; Bortolotti, M.;
Frayn, K.N.; Tappy, L. Sex differences in lipid and glucose kinetics after ingestion of an acute oral fructose
load. Br. J. Nutr. 2010, 104, 1139–1147. [CrossRef] [PubMed]
24. Karpe, F.; Steiner, G.; Olivecrona, T.; Carlson, L.A.; Hamsten, A. Metabolism of triglyceride-rich lipoproteins
during alimentary lipemia. J. Clin. Investig. 1993, 91, 748–758. [CrossRef] [PubMed]
25. Lecoultre, V.; Egli, L.; Carrel, G.; Theytaz, F.; Kreis, R.; Schneiter, P.; Boss, A.; Zwygart, K.; Le, K.A.;
Bortolotti, M.; et al. Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic
lipids in healthy humans. Obesity 2013, 21, 782–785. [CrossRef] [PubMed]
26. Johnston, R.D.; Stephenson, M.C.; Crossland, H.; Cordon, S.M.; Palcidi, E.; Cox, E.F.; Taylor, M.A.; Aithal, G.P.;
Macdonald, I.A. No difference between high-fructose and high-glucose diets on liver triacylglycerol or
biochemistry in healthy overweight men. Gastroenterology 2013, 145, 1016–1025.e2. [CrossRef]
27. Le, K.A.; Ith, M.; Kreis, R.; Faeh, D.; Bortolotti, M.; Tran, C.; Boesch, C.; Tappy, L. Fructose overconsumption
causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of
type 2 diabetes. Am. J. Clin. Nutr. 2009, 89, 1760–1765. [CrossRef]
28. Ngo Sock, E.T.; Le, K.A.; Ith, M.; Kreis, R.; Boesch, C.; Tappy, L. Effects of a short-term overfeeding with
fructose or glucose in healthy young males. Br. J. Nutr. 2010, 103, 939–943. [CrossRef]
29. Tappy, L.; Le, K.A. Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin. Res.
Hepatol. Gastroenterol. 2012, 36, 554–560. [CrossRef]
30. Donnelly, K.L.; Smith, C.I.; Schwarzenberg, S.J.; Jessurun, J.; Boldt, M.D.; Parks, E.J. Sources of fatty acids
stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Investig.
2005, 115, 1343–1351. [CrossRef]
31. Kotronen, A.; Yki-Jarvinen, H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler.
Thromb. Vasc. Biol. 2008, 28, 27–38. [CrossRef] [PubMed]
32. Ferramosca, A.; Zara, V. Modulation of hepatic steatosis by dietary fatty acids. World J. Gastroenterol. 2014,
20, 1746–1755. [CrossRef]
33. Teff, K.L.; Elliott, S.S.; Tschop, M.; Kieffer, T.J.; Rader, D.; Heiman, M.; Townsend, R.R.; Keim, N.L.;
D’Alessio, D.; Havel, P.J. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial
Nutrients 2019, 11, 209 12 of 12
suppression of ghrelin, and increases triglycerides in women. J. Clin. Endocrinol. Metab. 2004, 89, 2963–2972.
[CrossRef] [PubMed]
34. Stanhope, K.L.; Bremer, A.A.; Medici, V.; Nakajima, K.; Ito, Y.; Nakano, T.; Chen, G.; Fong, T.H.; Lee, V.;
Menorca, R.I.; et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides,
ldl-cholesterol, and apolipoprotein-b in young men and women. J. Clin. Endocrinol. Metab. 2011, 96,
E1596–E1605. [CrossRef] [PubMed]
35. Tappy, L. Thermic effect of food and sympathetic nervous system activity in humans. Reprod. Nutr. Dev.
1996, 36, 391–397. [CrossRef] [PubMed]
36. Calbet, J.A.; MacLean, D.A. Plasma glucagon and insulin responses depend on the rate of appearance of
amino acids after ingestion of different protein solutions in humans. J. Nutr. 2002, 132, 2174–2182. [CrossRef]
[PubMed]
37. Ramnanan, C.J.; Edgerton, D.S.; Kraft, G.; Cherrington, A.D. Physiologic action of glucagon on liver glucose
metabolism. Diabetes Obes. Metab. 2011, 13 (Suppl. 1), 118–125. [CrossRef]
38. Granger, D.N.; Richardson, P.D.; Kvietys, P.R.; Mortillaro, N.A. Intestinal blood flow. Gastroenterology 1980,
78, 837–863. [PubMed]
39. Ma, J.; Stevens, J.E.; Cukier, K.; Maddox, A.F.; Wishart, J.M.; Jones, K.L.; Clifton, P.M.; Horowitz, M.;
Rayner, C.K. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a
carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 2009, 32, 1600–1602. [CrossRef] [PubMed]
40. Le, M.T.; Frye, R.F.; Rivard, C.J.; Cheng, J.; McFann, K.K.; Segal, M.S.; Johnson, R.J.; Johnson, J.A. Effects
of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and
hemodynamic responses in healthy subjects. Metabolism 2012, 61, 641–651. [CrossRef] [PubMed]
41. Ahloulay, M.; Dechaux, M.; Laborde, K.; Bankir, L. Influence of glucagon on gfr and on urea and electrolyte
excretion: Direct and indirect effects. Am. J. Physiol. 1995, 269, F225–F235. [CrossRef] [PubMed]
42. Yu, T.F.; Sirota, J.H.; Berger, L.; Halpern, M.; Gutman, A.B. Effect of sodium lactate infusion on urate clearance
in man. Proc. Soc. Exp. Biol. Med. 1957, 96, 809–813. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
